Old Web
English
Sign In
Acemap
>
authorDetail
>
Kelly Griffis
Kelly Griffis
Medicine
B-cell lymphoma
in patient
Cancer research
Cell therapy
2
Papers
4
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase I Study of FT516, an Off-the-Shelf iPSC-Derived NK Cell Therapy, in Combination with Rituximab in Patients with Relapsed/Refractory B-Cell Lymphoma
2021
Blood
Krish Patel
Veronika Bachanova
Aaron M. Goodman
John M. Pagel
Kelly Griffis
Marlisa Anderson
Siminder Kaur Atwal
Cara Bickers
Peter Szabo
Wong Lilly L
Yu-Waye Chu
Rebecca Elstrom
Paolo Strati
Show All
Source
Cite
Save
Citations (0)
Preliminary results of a phase I trial of FT516, an off-the-shelf natural killer (NK) cell therapy derived from a clonal master induced pluripotent stem cell (iPSC) line expressing high-affinity, non-cleavable CD16 (hnCD16), in patients (pts) with relapsed/refractory (R/R) B-cell lymphoma (BCL).
2021
Journal of Clinical Oncology
Paolo Strati
Veronika Bachanova
Aaron M. Goodman
John M. Pagel
Januario E. Castro
Kelly Griffis
Marlisa Anderson
Siminder Kaur Atwal
Cara Bickers
Daniel Fremgen
Christina Ly
Sarah Cooley
Rebecca Elstrom
Krish Patel
Show All
Source
Cite
Save
Citations (4)
1